Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials

Affiliations

• ¹ Cancer Genomics, School of Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, UK.
• ² Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
• ³ Faculty of Engineering and Physical Sciences, School of Chemistry, University of Southampton, Southampton, UK.
• ⁴ Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
• ⁵ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
• ⁶ Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
• ⁷ Oxford National Institute for Health Research Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
• ⁸ Division of Haematology, University Hospitals Dorset, Bournemouth, UK.
• ⁹ Division of Haematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
• ¹⁰ Brighton and Sussex Medical School, University of Sussex, Brighton, UK.